Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9....

55
Professor Andrew Shennan Womens Academic Health Centre Kings College London, St Thomas’ Campus OAA Torquay 2015 NIHR, BIG data and how to avoid statistical errors

Transcript of Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9....

Page 1: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Professor Andrew ShennanWomens Academic Health CentreKings College London,St Thomas’ Campus OAA

Torquay

2015

NIHR, BIG data and how to avoid statistical errors

Page 2: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

“Compare like with like…..”

Page 3: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.
Page 4: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.
Page 5: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

To improve the health and wealth of the nation through research

National Institute for Health ResearchStrategic Aim

www.nihr.ac.uk

• Established in 2006 as part of “Best Research for Best Health”;a Government Strategy

• Budget approximately 1% of NHS spend (£1billion)

• Goals:• Transform research in the NHS• Increase the volume of applied health research for the

benefit of patients and the public• Develop and support the people who conduct and

contribute to applied health research• Support industry and growth

Page 6: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

The NIHR Health Research System

Research

Research Projects & Programmes

Research Governance

Systems

Research Information

Systems

Patients&

Public

Universities

Investigators &Senior

InvestigatorsAssociatesTrainees

Research Schools

NHS TrustsClinical Research Networks

Clinical Research Facilities, Centres

& Units

Infrastructure

Systems

Faculty

Page 7: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Clinical Specialties

Division 1

Cancer

Division 2

Cardiovascular

Diabetes

Metabolic & Endocrine

Renal

Stroke

Division 3

Children

Genetics

Haematology

Reproductive health & childbirth

Division 4

DENDRON

Mental health

Neurology

Division 5

Ageing

Dermatology

Health services research

Musculoskeletal

Oral & dental

Primary care

Public health

Division 6

Anaesthesia & pain

Critical care

Ear, nose & throat

Gastroenterology

Hepatology

ID & microbiology

Injuries & emergencies

Ophthalmology

Respiratory

Surgery

Page 8: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Number of Open Studies by main topic (UK-wide)

0

100

200

300

400

500

600

Page 9: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Anaesthesia:Plenty of Scope for doing more!

Page 10: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

RESPITEA Randomised Controlled Trial of Remifentanil intravenous Patient Controlled analgesia (PCA) versus intramuscular

pethidine for pain relief in labour

ISRCTN29654603 EUDRACT # 2012-005257-22

Page 11: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Effect site concentration

Remifentanil

Alfentanil

Sufentanil

Pethidine

Page 12: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Remifentanil vs. Pethidine Superior analgesia↑Maternal satisfaction Sedation similar

Fetal effects equivalentHeart Rate APGAR 5°AcidosisNeurobehavioral

Page 13: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

The Health and Social Care Act (2012)

• Places a clear duty on the Secretary of State, the NHS

Commissioning Board and Clinical Commissioning Groups to

promote research on matters relevant to the health service,

and the use in the health service of evidence obtained from

research

• NHS Constitution: clinical research is “core business” for the

NHS; patients have a right to participate in a clinical trial if

they are suitable for it

• Rapid adoption of effective innovations to characterise NHS

Page 14: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

NHS Constitution: article 3a includes a "pledge" to inform patients when they "may

be eligible" to participate in a research study

Page 15: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Respite trial: PPI rep

"I wanted to take part. I read about it, tried to meet people who could help, and even put it in my birth plan. They just weren't interested. It was really upsetting."

Page 16: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Hierarchy of evidence based medicine

Individual experienceCollective experience

Case reportCase series

Cohort: observationalCohort: case control

Randomised Controlled TrialsMeta-analysis of RCTs

Page 17: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

EvidenceWe don’t have to study everything

Parachute or snowboard, jumping out of a plane?

Page 18: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Evidence• Doing the study dosn’t always mean we

find the right answer: generalisability

Page 19: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Case reports• Hall M, Vousden N, Carter J, Hezelgrave N, Shennan AH.

Prevention of mid-trimester loss following full dilatation caesarean section: a potential role for transabdominal cervical cerclage. J Obstet Gynaecol. 2015 Jan;35(1):98-9. doi: 10.3109/01443615.2014.940302.

• Anderson-Knight HE, Hezelgrave NL, Shennan AH. Spontaneous resolution of a midtrimester dilated cervix with expectant management guided by quantitative fetal fibronectin results. J Obstet Gynaecol. 2015 Mar 16:1-2. [Epub ahead of print] No abstract available. PMID:25774648

• Calvert B, Hezelgrave N and Shennan AH. Successful vaginal delivery following an abdominal cerclage, predicted by serial vaginal cervical ultrasound. J Obstet Gynaecol 2015. In press.

Page 20: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.
Page 21: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Statistical errors….lies, damn lies and statistics

Page 22: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Statistical Errors

• 0 Right answer wrong question• 1 A difference exists that isn't real• 2 No difference is found when one exists• 3 Significant answer, wrong direction• 4 Errors in assays, machines, labelling• 5 Made up, fraudulent

Page 23: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Type 1 error (Plausibility)• RCT• Placebo controlled• Predefined primary endpoint; pre-

eclampsia• Predefined analysis• Significant difference: RRR 0.8 (CI 0.71 –

0.89), p <0.001• Population:Odd numbers vs even numbers

Page 24: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Type 1 error (predefined endpoint)

05

10152025

Number of women with

pre-eclampsia

Intention-to-treat

Completedstudy

PlaceboVitamins C and E

Page 25: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Effect of vitamins on PAI-1/PAI-2 ratio

Gestation (weeks)

20 24 28 32 36

PAI-1

/PAI

-2 ra

tio

0.15

0.20

0.25

0.30

0.35

0.40

0.45

0.50Control Placebo Vitamin

Chappell et al 2002

Predefined primary endpoint

Page 26: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Why is p < 0.05?Alpha, or chance of False Positive? Because we have 5 fingers

Page 27: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Fetal Monitoring: Type 2 errors?

Page 28: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Randomised trials

• INFANT

– Intelligent decision support in the interpretation of the intrapartum CTG in labour - 46,000 women

– Eligibility – women who are judged to require continuous electronic fetal monitoring in labour

– Outcome – NE, IP stillbirth

Page 29: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

INFANT

Page 30: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Infant: Primary outcome

• “Poor neonatal outcome”:• Deaths (excluding congenital anomalies):

– Intrapartum stillbirth

– Neonatal

• Neonatal encephalopathy:– Severe/moderate– Mild

• Other significant morbidity:– Other admissions to NICU within 48 hrs of birth for ≥ 48

hrs e.g. respiratory symptoms, seizures

• Developmental quotient at age 2 years

Page 31: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

INFANT Sample size

Assuming: Poor neonatal outcome rate:3 per1000 births• 5% significance level • 90% power

– 50% reduction in poor neonatal outcome rate e.g. to compare 3 versus 1.5 per 1000

Need: 46,000 births in total (22,279 per arm)

Page 32: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

RCT (event rate also important) Seat belt vs No seat belt

20,000,000Car

Journeys/day

10,000,000Seat Belt

10,000,000No Seat Belt

Page 33: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

RCT: Seat belt vs No seat belt

20,000,000Car

Journeys/day

Seat Belt2 deaths

No Seat Belt8 deaths

Page 34: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Conclusions?

• Seat belts do not save lives, and should be abandoned as they limit the comfort and mobility of the passenger.

Page 35: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Conclusion

• This study is underpowered to determine the effect of seat belts on saving lives.

Page 36: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Type 3 error

Proportion of mothers giving birth, by gestational ageand randomised treatment: A[___] or B[---]

Pro

porti

on d

eliv

ered

Gestational age at birth (weeks)0 10 20 30 4024 37

0.00

0.25

0.50

0.75

1.00

A

B

Page 37: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

0

10

20

30

40

50

60

70

Placebo Roficoxib

Page 38: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET

Study

BJOG. 2006 Jan;113(1):65-74Andrew Shennan, Sarah Crawshaw, Annette Briley,

Jenny Hawken, Paul Seed, Griff Jones, Lucilla Poston

0%

10%

20%

30%

40%

50%

60%

70%

Metronidazole Placebo

PTB

N=900 screened / 100 randomised

Page 39: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Risk Ratio

.1 1 10

Combined

Premet, 2004

Odendaal H et al., 2002

Klebanoff M et al., 2001

Carey J et al., 2000

McDonald H et al., 1997

Morales W et al., 1994

Studies involving metronidazole without erythromycin only

Page 40: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Type 4 error

0

10

20

30

40

50

60

70

Trad CSE LDI

COMET trial

Page 41: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Effect of low-dose mobile versus traditional epidural techniques on mode of delivery: a

randomised controlled trialThe Lancet, Volume 358, Issue 9275,

Pages 19 - 23, 7 July 2001The COMET study Group Shennan et al.

05

1015202530354045

Trad CSE LDI

% SVD

N=1054 (x2)

P=0.04

Page 42: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Cochrane: feeding is safe?Type 0?? Right answer, wrong question

A Randomised Controlled Trial to Evaluate the Effect of Food intake during Labour

on Obstetric Outcome

0%5%

10%15%20%25%30%35%40%45%

Food Water

SVD N=2500

Page 43: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Num

ber o

f dea

ths

Middle year of triennium

Maternal deaths due to anaesthesia(1952-2008)

Page 44: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Beware the hidden agenda!Restricting oral intake in labour

“No benefit or harm, therefore do not restrict……”

Page 45: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

?

• No studies looked specifically at women at increased risk of complications, hence there is no evidence to support restrictions in this group of women.

Page 46: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Should women drink/eat during labor ?

We will never have the clinical trial evidence to ensure safety but in recent years we have seen….

• No increase in pulmonary aspiration– (4 deaths in 10,000,000 deliveries in UK)

In spite of….• Considerable Increase in feeding practice• Increase in C/S and therefore now GAs

Page 47: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Type 5 error…..Malcolm Pearce

• Obstetrician suspended after research inquiry.

• Faked a report about transplantation of an ectopic pregnancy.

Page 48: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Upright versus recumbent position in the second stage of labour in women with combined spinal-epidural

analgesiaM. Golara, MRCOG, F. Plaat, FRCA, A.H. Shennan, MD

MRCOGInt J Obstet Anesth. 2002 Jan;11(1):19-22

0

20

40

60

80

100

120

140

Upright Recumbant

Length labour(minutes)

N=66

Page 49: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

NIHR Health Technology Assessment ProgramISRCTN 35706297

Page 50: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Research model

Multicentre RCT41 UnitsN=30501 year pilot phase2 years recruitment

£3.2M

Page 51: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Singleton, cephalic, term, nulliparaeMobile epidural

Upright Lying Down

Enter 2nd Stage

Power: 0.9 To detect a RR SVD

0.6

N=3237Reporting 2015

Page 52: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Funding bodies

WellcomeMRCNIHR HTA RfPB Fellowships

National Charities“The harder it is, the less likely someone

else is going to do it.”

Page 53: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Conclusion• Research informs everything we do• Research active clinicians have better outcomes• We have an obligation to offer research to our

patients, and many want it• Publishing your experience disseminates your

knowledge to many and forever• Research is personally rewarding• UK provides a globally unique opportunity to

engage with health research• Academics live longer

Page 54: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

Geraldine O’Sullivan

Befriend an Obstetric AnaethetistBefriend a clinical academic

Page 55: Professor Andrew Shennan Womens Academic Health Centre ...Obstet Gynaecol. 2015 Jan;35(1):98 -9. doi: 10.3109/01443615.2014.940302. • Anderson-Knight HE, Hezelgrave NL, Shennan AH.

The Future….

Anaesthesia and perioperative care priority setting partnership